Surgery Partners

Q2 FY2026 EarningsQ2 FY2026 results showed a slight top-line beat but significant bottom-line pressure: revenue of $848.9M beat consensus by 2.24%, yet GAAP EPS of -$0.12 missed the expected -$0.07. While same-facility revenue grew 5.0% YoY driven by pricing (+4.8% per case), Adjusted EBITDA declined 2.9% YoY to $125.2M. Full-year FY26 guidance was reaffirmed, but the pending Idaho Falls divestiture and rising interest expenses remain key focal points for the second half.